This study investigates how certain biomarkers, which are signs in your genes that indicate how well your body responds to treatment, change before, during, and after standard care for non-small cell lung cancer (NSCLC). The purpose of this study is to better understand the genetic changes that occur over the course of treatment for NSCLC, a type of lung cancer.
Participants will undergo procedures including blood draws to monitor these genetic changes. The study will involve comparing the biomarkers in NSCLC patients with those in healthy controls to identify any significant differences or patterns.
- Who can participate: Adults aged 18 and older with confirmed NSCLC, either stage IV or recurrent, who are either treatment-naïve or have had prior chemotherapy, are eligible. Healthy adults willing to undergo a blood draw may also participate.
- Study details: Participants will have blood samples taken at different times to study changes in their genes. Healthy controls will also provide blood samples for comparison. A placebo is not used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand
